2-arylimino-2,3-dihydrothiazole derivatives, methods for...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 277/42 (2006.01) A61K 31/425 (2006.01) C07D 241/00 (2006.01) C07D 277/00 (2006.01) C07D 277/38 (2006.01) C07D 417/04 (2006.01) C07D 417/06 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2434203

The invention concerns novel 2-arylimino-2,3-dihydrothiazole derivatives, the methods for preparing them and their use as medicines, in particular for treating pathological conditions or diseases wherein one (or several) somatostatin receptors are involved. Said conditions include in particular acromegaly, hypophisial adenoma or endocrinal gastroentero-pancreatic tumours including the carcinoid syndrome, and gastrointestinal bleeding.

L'invention a pour objet de nouveaux dérivés de 2-arylimino-2,3- dihydrothiazoles, leurs procédés de préparation et leur utilisation en tant que médicaments, en particulier dans le traitement des états pathologiques ou des maladies dans lesquels un(ou plusieurs) des récepteurs de la somatostatine est(sont) impliqué(s). Ces états incluent en particulier l'acromégalie, les adénomes hypophysaires ou les tumeurs gastroentéropancréatiques endocriniennes dont le syndrome carcinoïde, et les saignements gastro-intestinaux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

2-arylimino-2,3-dihydrothiazole derivatives, methods for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-arylimino-2,3-dihydrothiazole derivatives, methods for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-arylimino-2,3-dihydrothiazole derivatives, methods for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1677955

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.